Key result
Cardiac PET and PET/CT provide valuable diagnostic and management utility across CAD and myocardial viability.
Answers are grounded in this paper and cite their sources.
The present review provides an overview of the role of cardiac positron emission tomography in the diagnosis and management of cardiovascular disease. It expands on the relative advantages and disadvantages over other imaging modalities as well as the available evidence supporting its value in the diagnosis and management of patients with coronary artery disease, the assessment of myocardial viability, and evaluation of the cardiac sympathetic nervous system. Furthermore, the recent developments, such as the implementation of high-end computed tomography devices to form hybrid systems, and the advances of molecular imaging probes in experimental applications are briefly discussed.
No takes yet. Share an insight, caveat, or question.
Gaemperli et al. (2011) conducted a review in Cardiovascular disease. Cardiac positron emission tomography (PET and PET/CT) was evaluated. Cardiac positron emission tomography and PET/CT serve as valuable imaging modalities for the diagnosis and management of cardiovascular disease, coronary artery disease, and myocardial viability.
Synapse has enriched 10 related papers. Consider them for comparative context: